 SEATTLE and VANCOUVER, BC, Oct. 27, 2020 PRNewswire --Achieve Life Sciences, Inc. NASDAQ: ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the Company... 